Skip to main content
Log in

Differential growth inhibition and enhancement of major histocompatibility complex class I antigen expression by interferons in a small-cell lung cancer cell line and its doxorubicin-selected multidrug-resistant variant

  • Short communication
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

Expression of class I and class II major histocompatibility complex antigens on a human small-cell lung cancer cell line and its multidrug-resistant variant was examined before and after exposure to interferon α (IFNα) and IFNγ by flow cytometry. Neither IFNα nor IFNγ induced class II antigen expression on the drug-sensitive or resistant cell line. Induction of class I antigen expression along with an inhibition of proliferation was observed in both cell lines after IFNα treatment. On the other hand, IFNγ treatment resulted in growth inhibition and enhancement of class I antigen expression in the sensitive cell line but not the resistant cell line. The differential response of the two cell lines to IFNγ cannot be directly attributed to the acquisition of drug resistance but it suggests that further investigation of the possibility that drug-sensitive and resistant small-cell lung tumors may respond differently to immunotherapies that include IFNγ is warranted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Ball ED, Sorenson GD, Pettengill OS (1986) Expression of myeloid and major histocompatibility antigens on small cell carcinoma of the lung cell lines analyzed by cytofluorography: modulation by γ-interferon. Cancer Res 46: 2335

    PubMed  Google Scholar 

  2. Beck LK, Kane MA, Bunn PA (1988) Innovative and future approaches to small cell lung cancer treatment. Semin Oncol 15: 300

    PubMed  Google Scholar 

  3. Bepler G, Carney DN, Nau MM, Gazdar AF, Minna JD (1986) Additive and differential biological activity of α interferon A, difluoromethylornithine, and their combination on established human lung cancer cell lines. Cancer Res 46: 3413

    PubMed  Google Scholar 

  4. Cole SPC (1990) Patterns of cross-resistance in a multidrug-resistant small-cell lung carcinoma cell line. Cancer Chemother Pharmacol 26: 250

    PubMed  Google Scholar 

  5. Doyle A, Martin WJ, Funa K, Gazdar A, Carney D, Martin SE, Linnoila I, Cuttitta F, Mulshine J, Bunna P, Minna J (1985) Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer. J Exp Med 161: 1135

    PubMed  Google Scholar 

  6. Driggers PH, Ennist DL, Gleason SL, Mak W-H, Marks MS, Levi B-Z, Flanagan JR, Appella E, Ozato K (1990) An interferon γ-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes. Proc Natl Acad Sci USA 87: 3743

    PubMed  Google Scholar 

  7. Elliott BE, Carlow DA, Rodricks A-M, Wade A (1989) Perspectives on the role of MHC antigens in normal and malignant cell development. Adv Cancer Res 53: 181

    PubMed  Google Scholar 

  8. Funa K, Gazdar AF, Minna JD, Linnoila RI (1986) Paucity of β2-microglobulin expression on small cell lung cancer, bronchial carcinoids, and certain other neuroendocrine tumors. Lab Invest 55: 186

    PubMed  Google Scholar 

  9. Jabbar SAB, Twentyman PR, Watson JV (1989) The MTT assay underestimates the growth inhibitory effects of interferons. Br J Cancer 60: 523

    PubMed  Google Scholar 

  10. Lampson LA, Fisher CA, Whelan JP (1983) Strinking paucity of HLA-A,B,C and β2-microblobulin on human neuroblastoma cell lines. J Immunol 130: 2471

    PubMed  Google Scholar 

  11. Levy DE, Kessler DS, Pine R, Reich N, Darnell Jr JE (1988) Interferon-induced nuclear factors that bind a shared promoter element correlate with positive and negative transcriptional control. Genes Dev 2: 383

    PubMed  Google Scholar 

  12. Mirski SEL, Gerlach JH, Cole SPC (1987) Multidrug resistance in a human small cell lung cancer cell line selected in Adriamycin. Cancer Res 47: 2594

    PubMed  Google Scholar 

  13. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55

    PubMed  Google Scholar 

  14. Olsson L, Behnke O, Sorensen HR (1985) Modulatory effects of 5-azacytidine, phorbol ester, and retinoic acid on the malignant phenotype of human lung cancer cells. Int J Cancer 35: 189

    PubMed  Google Scholar 

  15. Ottesen SS, Ahrenkiel V, Kieler J (1990) Recombinant human interferon γ exerts an anti-proliferative effect and modulates the expression of human leukocyte antigens A,B,C and DR in human urothelial cell lines. Cancer Immunol Immunother 31: 93

    PubMed  Google Scholar 

  16. Parham P, Barnstable CJ, Bodmer WF (1979) Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B,C antigens. J Immunol 123: 342

    PubMed  Google Scholar 

  17. Ruff MR, Farrar WL, Pert CB (1986) Interferon γ and granulocyte/macrophage colony-stimulating factor inhibit growth and induce antigens characteristic of myeloid differentiation in small-cell lung cancer cell lines. Proc Natl Acad Sci USA 83: 6613

    PubMed  Google Scholar 

  18. Schmid I, Schmid P, Giorgi JV (1988) Conversion of logarithmic channel numbers into relative linear fluorescence intensity. Cytometry 9: 533

    PubMed  Google Scholar 

  19. Schwartz R, Momburg F, Moldenhauer G, Dorken B, Schirrmacher V (1985) Induction of HLA class-II antigen expression on human carcinoma cell lines by IFN-gamma. Int J Cancer 35: 245

    PubMed  Google Scholar 

  20. Stam NJ, Kast WM, Woordouw AC, Pastoors LB, Van der Hoeven FA, Melief CJM, Ploegh HL (1989) Lack of correlation between levels of MHC class I antigen and susceptibility to lysis of small cellular lung carcinoma (SCLC) by natural killer cells. J Immunol 142: 4113

    PubMed  Google Scholar 

  21. Ucer U, Bartsch H, Scheurich P, Pfizenmaier K (1985) Biological effects of γ-interferon on human tumor cells: quantity and affinity of cell membrane receptors for γ-IFN in relation to growth inhibition and induction of HLA-DR expression. Int J Cancer 36: 103

    PubMed  Google Scholar 

  22. Viallet J, Ihde DC (1989) Systemic therapy for small-cell lung cancer: old themes replayed, new ones awaited. J Clin Oncol 7: 985

    PubMed  Google Scholar 

  23. Weynants P, Wauters P, Coulie PG, Van Den Eynde B, Symann M, Boon T (1988) Cytolytic response of human T cells against allogeneic small cell lung carcinoma treated with interferon gamma. Cancer Immunol Immunother 27: 228

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cole, S.P.C., Campigotto, B.M.T., Johnson, J.G. et al. Differential growth inhibition and enhancement of major histocompatibility complex class I antigen expression by interferons in a small-cell lung cancer cell line and its doxorubicin-selected multidrug-resistant variant. Cancer Immunol Immunother 33, 274–277 (1991). https://doi.org/10.1007/BF01744948

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01744948

Keywords

Navigation